Xuan Hong
- Cancer Research top 10%
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Oncology top 10%
- Lung Cancer Research Studies 8
-
- Lung Cancer Treatments and Mutations 6
-
- Neuroendocrine Tumor Research Advances 3
-
- interferon and immune responses 2
-
- Anesthesia and Pain Management 2
-
- Electromagnetic Compatibility and Noise Suppression 2
- Co-authors
- Zhaoyang YangBaohong CuiMeng WangQingyong XuLi WangFang� YangLeiguang YeYina Gao
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Journal of Agricultural and Food Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Xuan Hong
33 papers receiving 740 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 220
- Oncology 394
- Pulmonary and Respiratory Medicine 164
- Internal Medicine 17
- Molecular Biology 286
Countries citing papers authored by Xuan Hong
This map shows the geographic impact of Xuan Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Hong more than expected).
Fields of papers citing papers by Xuan Hong
This network shows the impact of papers produced by Xuan Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Hong. The network helps show where Xuan Hong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuan Hong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 8 | |
| 9 | 2020 | 21 | |
| 10 | 2020 | 82 | |
| 11 | 2017 | 29 | |
| 12 | 2016 | 14 | |
| 13 | 2015 | 45 | |
| 14 | 2014 | 4 | |
| 15 | 2013 | 24 | |
| 16 | 2013 | 18 | |
| 17 | 2012 | 17 | |
| 18 | 2011 | 9 | |
| 19 | 2011 | 33 | |
| 20 | [Establishment of a multi drug-resistant human lung adenocarcinoma cell line and biological characteristics there of]. | 2007 | 3 |
About Xuan Hong
Xuan Hong is a scholar working on Cancer Research, Oncology and Anesthesiology and Pain Medicine, having authored 36 papers that have together received 750 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (6 papers), MicroRNA in disease regulation (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), interferon and immune responses (2 papers), Anesthesia and Pain Management (2 papers) and Electromagnetic Compatibility and Noise Suppression (2 papers). The work is most often cited by research in Cancer Research (220 citations), Oncology (394 citations) and Pulmonary and Respiratory Medicine (164 citations). Xuan Hong has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Zhaoyang Yang, Baohong Cui, Meng Wang, Qingyong Xu, Li Wang, Meng Wang, Fang� Yang, Leiguang Ye, Yina Gao and Baogang Liu. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Agricultural and Food Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.